Chemomab Therapeutics Ratios (2017-2025) | CMMB

Ratios Dec2017 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Efficiency
Assets Average (Quarter)
36.30M65.32M68.98M65.90M62.65M58.67M53.30M46.64M39.04M31.93M26.13M22.78M20.08M16.28M17.72M18.93M14.89M11.97M11.75M13.09M
Equity Average (Quarter)
32.98M61.60M66.78M63.49M59.35M54.54M48.23M40.42M32.09M24.97M20.02M17.52M15.16M11.66M13.15M14.93M11.96M10.05M10.46M11.78M
Invested Capital (Quarter)
55.16M68.04M65.51M61.47M57.24M51.84M44.62M36.22M27.95M21.99M18.04M17.00M13.33M9.98M16.32M13.54M10.39M9.70M11.23M12.33M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
15.03-33.09-20.7428.5531.64-16.90-6.9322.4927.5016.34100.7118.08160.57
Equity Ratio (Quarter)
0.920.960.970.960.940.920.890.840.800.760.770.770.740.690.780.800.810.870.910.89
Times Interest Earned (Quarter)
15.03-33.09-20.7428.5531.64-16.90-6.9322.4927.5016.34100.7118.08160.57
Valuation
Enterprise Value (Quarter)
-58.20M-66.92M-64.27M-15.19M-57.41M-51.72M-46.54M-13.60M-32.71M-10.46M-9.23M-9.37M-4.74M-5.18M-6.68M-6.15M-8.48M-5.74M-7.12M-10.37M
Return Ratios
Return on Capital Employed (Quarter)
-5.76%-16.40%-31.59%-26.85%-10.86%10.28%44.71%99.83%131.32%139.82%134.48%122.01%122.88%108.53%-86.88%-149.41%-308.65%
Return on Invested Capital (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.01%0.01%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.01%0.01%0.01%0.01%0.01%0.01%-0.01%-0.01%-0.02%-0.02%-0.01%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.01%0.01%0.01%0.01%0.01%0.01%-0.01%-0.01%-0.02%-0.02%-0.01%